ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 44 | November 19, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

Bunn To Succeed Norton As ASCO President, Tempero Is President-Elect

April 26, 2002

DOD Breast Cancer Program Releases Research Solicitation

October 1, 1993

RFA: Long-Term Cancer Survivors

September 12, 1997